Clinical Psychopharmacology Education For Mental Health Professionals

The Psychopharmacology Institute is an ongoing project aimed to provide unbiased, evidence-based online education in clinical psychopharmacology.

Become a Premium Member

Free Subscription

From Our Video Library

Bupropion-PsychopharmacologyThe Psychopharmacology of Bupropion: An Illustrated Overview

This presentation reviews the essential aspects of this medication including: mechanism of action, indications, pharmacokinetics, adverse effects profile and dosing guidelines.



ssri-moa-5The Mechanism of Action of SSRIs

This video discusses the role of 5-HT1A receptor downregulation in the mechanism of action of SSRIs. The monoamine theory of depression is also reviewed and contrasted with its limitations.



Adverse Effects of SSRIs

This brief video is an overview on the most common side effect of selective serotonin reuptake inhibitors.

Possible mechanisms for each side effect are also discussed.

Featured Articles

first_generation_antipsychotics-related_conceptsFirst Generation Antipsychotics: An Introduction

Learn about the terminology, mechanism of action, classifications and potency of typical or conventional antipsychotics.



buspirone-mechanism-of-actionSerotonin 5-HT1A Receptors in Psychopharmacology

This illustrated article explores the clinical neuropharmacology of 5-HT1A receptors. The role these receptors play in anxiety, depression and schizophrenia is also discussed.

Expert Interviews

Treatment-Resistant Depression

prakash_masand_treatment_resistant_depressionIn this audio interview we discuss with Dr. Prakash Masand the pharmacological management of treatment-resistant depression.

Prakash Masand, M.D., is Founder, Chairman, and CEO of Global Medical Education (GME). Dr. Masand was also Consulting Professor of Psychiatry and Behavioral Sciences at Duke University Medical Center in Durham, NC. He previously served as Director of Therapeutic Area Development, Neurosciences Medicine at the Duke Clinical Research Institute.

Click here for the full interview